![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
[email protected]Shown: posts 20 to 44 of 69. Go back in thread:
Posted by detroitpistons on March 12, 2010, at 23:08:09
In reply to Re: My letter to the FDA » detroitpistons, posted by evenintherain on March 12, 2010, at 22:06:49
Amazing! What a coincidence. Thank you so much!
> dp, i have written my aunt a long e-mail about my cymbalta withdrawal and included your e-mail to the committee. after looking around on the site i confirmed that she is actually one of the 11 voting members of the committee and is the consumer advocate, so it may be that she is actually the person who should be getting your e-mail in the first place!
> what a happy coincidence.
>
> i will inform you of her response as soon as i get it.
Posted by ed_uk2010 on March 13, 2010, at 9:20:21
In reply to Re: My letter to the FDA » evenintherain, posted by detroitpistons on March 12, 2010, at 23:08:09
How popular is Pristiq in the US? We don't even have Pristiq here. I guess Wyeth decided not to bother marketing it because they know full well that our doctors will be told not to prescribe it (which is exactly what happened to Cymbalta). Every time a patent-extender comes out, our doctors get told not to prescribe it! This is bad news for the pharmaceutical industry but it does have its advantages.
Posted by evenintherain on March 13, 2010, at 13:41:38
In reply to Re: My letter to the FDA » detroitpistons, posted by ed_uk2010 on March 13, 2010, at 9:20:21
Hi, here is her response.
She is going to give some serious thought on how to bring the SNRI discontinuation issue to the proper people at the FDA. She is also going to find out to what extent they are already looking at this issue.
in the meantime, anyone who has complaints should definitely register them here: http://www.fda.gov/safety/MedWatch/default.htm
MedWatch is the registry for all adverse events.
ALSO:
The doctor who is head of psychopharm for the FDA and steers the committee is Dr. Thomas Laughren. His contact info is below. Definitely have people concerned about this issue contact him. He is, after all, a public servant. And this is his missive.
Laughren, Thomas P
FDA
DHHS/FDA/CDER/OND/ODEI/DPP
SUPERVISORY MEDICAL OFFICER
WO22
4114
Silver Spring MD 20993
301-796-2260
301-796-9841
[email protected]Anyway, my aunt is taking this very seriously and did experience discontinuation syndrome herself (with cymbalta) so knows it needs to be addressed. i am glad you got me to contact her!
she added "BTW, I do remember getting [someone's] very thoughtful email on this issue addressed to the committee writ large, so obviously the FDA forwarded it to all of the members of the committee."
Posted by evenintherain on March 13, 2010, at 13:58:20
In reply to Re: My letter to the FDA » evenintherain, posted by detroitpistons on March 12, 2010, at 23:08:09
might i suggest you add the medwatch link to your petition?
http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053074.htm
i would spread this link around as much as possible. i'm sure if more people take the time and effort to fill out this form and send it in the FDA will definitely take this issue seriously.
Posted by detroitpistons on March 13, 2010, at 14:02:08
In reply to Re: My letter to the FDA » detroitpistons, posted by ed_uk2010 on March 13, 2010, at 9:20:21
Ed,
You have no idea how messed up things are over here! Well, you probably do, but that's besides the point...Regardless of what people think of the NHS, at least they don't fall for this patent extender crap.
Here in the States, I think that most independent, scientific panels of doctors and researchers have the exact same mentality as the NHS. They will not have the wool pulled over their eyes.
However, now picture the private, for profit psychiatric offices - the actual doctors in the field. They are visited frequently by drug reps, and for some reason, they believe what the drug reps say, or they're somehow in bed with the drug reps. It's a total conflict of interest. Some doctors are just borderline crooked. I used to work as a buyer for industrial raw materials, and I can say that most companies prohibit accepting gifts from suppliers. Such is not the case for doctors. Here's a pretty good article:
http://www.scu.edu/ethics/publications/submitted/morreim/prescribing.html
Bottom line...They stop getting Effexor samples and start getting Pristiq samples. So what do they do? They put people on Pristiq, even if there is no evidence of "clinically significant" advantages. Just browsing around the "internets," I can see that many, many people are being transitioned over to Pristiq. For what? So yes, Pristiq is becoming the dominant form of venlafaxine over here.
At the same time, Osmotica Pharmaceuticals now makes an extended release venlafaxine tablet**. I know they provide samples, so I don't understand the sudden rush to transition to Pristiq. Well, I do. Drug reps have these doctors in their back pockets.
**Get this, due to patent litigation, companies like Osmotica aren't allowed to make a direct equivalent to Effexor XR quite yet. They can't make extended release beads packaged in capsules. Therefore, they have to make extended release venlafaxine in tablet form. Because of this, it is not considered a "true" generic/ substitute. This is all so silly. It borders on circus-like ridiculousness.
> How popular is Pristiq in the US? We don't even have Pristiq here. I guess Wyeth decided not to bother marketing it because they know full well that our doctors will be told not to prescribe it (which is exactly what happened to Cymbalta). Every time a patent-extender comes out, our doctors get told not to prescribe it! This is bad news for the pharmaceutical industry but it does have its advantages.
>
>
Posted by detroitpistons on March 13, 2010, at 14:04:00
In reply to How to contact the FDA if you have drug concerns, posted by evenintherain on March 13, 2010, at 13:41:38
evenintherain,
You are the best! This is so incredibly awesome!
> Hi, here is her response.
>
> She is going to give some serious thought on how to bring the SNRI discontinuation issue to the proper people at the FDA. She is also going to find out to what extent they are already looking at this issue.
>
> in the meantime, anyone who has complaints should definitely register them here: http://www.fda.gov/safety/MedWatch/default.htm
>
> MedWatch is the registry for all adverse events.
>
> ALSO:
>
> The doctor who is head of psychopharm for the FDA and steers the committee is Dr. Thomas Laughren. His contact info is below. Definitely have people concerned about this issue contact him. He is, after all, a public servant. And this is his missive.
>
>
> Laughren, Thomas P
> FDA
> DHHS/FDA/CDER/OND/ODEI/DPP
> SUPERVISORY MEDICAL OFFICER
> WO22
> 4114
> Silver Spring MD 20993
> 301-796-2260
> 301-796-9841
> [email protected]
>
> Anyway, my aunt is taking this very seriously and did experience discontinuation syndrome herself (with cymbalta) so knows it needs to be addressed. i am glad you got me to contact her!
>
> she added "BTW, I do remember getting [someone's] very thoughtful email on this issue addressed to the committee writ large, so obviously the FDA forwarded it to all of the members of the committee."
Posted by ed_uk2010 on March 13, 2010, at 14:23:17
In reply to Re: My letter to the FDA » ed_uk2010, posted by detroitpistons on March 13, 2010, at 14:02:08
Hi DP,
Very interesting post. Personally, I think that samples are a big part of the problem. The most that doctors get from drug reps over here is pens and note pads! I think it's important to bear in mind that there is nothing generous about samples ie. the entire purpose is to get as many people as possible onto a new and usually very expensive product which will certainly not continue to be available for free in the long run.
Wyeth discontinued Effexor tablets in the UK a while ago due to low prescribing (generics are available). They still do the m/r caps but there is now very low demand for these too. Most people have been on the generic for 18 months plus. I guess Wyeth were less successful in protecting their patent here!
> You have no idea how messed up things are over here! Well, you probably do, but that's besides the point...Regardless of what people think of the NHS, at least they don't fall for this patent extender crap.
>
> Here in the States, I think that most independent, scientific panels of doctors and researchers have the exact same mentality as the NHS. They will not have the wool pulled over their eyes.
>
> However, now picture the private, for profit psychiatric offices - the actual doctors in the field. They are visited frequently by drug reps, and for some reason, they believe what the drug reps say, or they're somehow in bed with the drug reps. It's a total conflict of interest. Some doctors are just borderline crooked. I used to work as a buyer for industrial raw materials, and I can say that most companies prohibit accepting gifts from suppliers. Such is not the case for doctors. Here's a pretty good article:
>
> http://www.scu.edu/ethics/publications/submitted/morreim/prescribing.html
>
> Bottom line...They stop getting Effexor samples and start getting Pristiq samples. So what do they do? They put people on Pristiq, even if there is no evidence of "clinically significant" advantages. Just browsing around the "internets," I can see that many, many people are being transitioned over to Pristiq. For what? So yes, Pristiq is becoming the dominant form of venlafaxine over here.
>
> At the same time, Osmotica Pharmaceuticals now makes an extended release venlafaxine tablet**. I know they provide samples, so I don't understand the sudden rush to transition to Pristiq. Well, I do. Drug reps have these doctors in their back pockets.
>
> **Get this, due to patent litigation, companies like Osmotica aren't allowed to make a direct equivalent to Effexor XR quite yet. They can't make extended release beads packaged in capsules. Therefore, they have to make extended release venlafaxine in tablet form. Because of this, it is not considered a "true" generic/ substitute. This is all so silly. It borders on circus-like ridiculousness.
>
> > How popular is Pristiq in the US? We don't even have Pristiq here. I guess Wyeth decided not to bother marketing it because they know full well that our doctors will be told not to prescribe it (which is exactly what happened to Cymbalta). Every time a patent-extender comes out, our doctors get told not to prescribe it! This is bad news for the pharmaceutical industry but it does have its advantages.
> >
> >
>
>
Posted by detroitpistons on March 13, 2010, at 15:10:23
In reply to Re: My letter to the FDA, posted by evenintherain on March 13, 2010, at 13:58:20
You're absolutely right...This form has much, much more credibility than those online petitions. In fact, I don't think I'm going to focus much on that anymore because I don't think online petitions are taken very seriously.
> might i suggest you add the medwatch link to your petition?
>
> http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053074.htm
>
> i would spread this link around as much as possible. i'm sure if more people take the time and effort to fill out this form and send it in the FDA will definitely take this issue seriously.
Posted by evenintherain on March 13, 2010, at 15:38:55
In reply to Re: My letter to the FDA » evenintherain, posted by detroitpistons on March 13, 2010, at 15:10:23
i think anything that documents or gets patient complaints in writing is probably helpful. i don't want to be seen as some anti-drug crusader or conspiracy theorist (because i'm neither!) but i don't think your petition implies that at all.
Posted by linkadge on March 14, 2010, at 11:18:07
In reply to Venlafaxine Suspension, posted by ed_uk2010 on March 12, 2010, at 16:12:52
to come off effexor I just opened the 37.5mg caps and counted pellets.
So 1 37.5 was an average of 120 pellets I'd come down by say 20 pellets every few days.
Linkadge
Posted by detroitpistons on March 14, 2010, at 12:51:38
In reply to Re: Venlafaxine Suspension, posted by linkadge on March 14, 2010, at 11:18:07
Yeah. You shouldn't have to do that. It should already be done for you. It's infuriating.
> to come off effexor I just opened the 37.5mg caps and counted pellets.
>
> So 1 37.5 was an average of 120 pellets I'd come down by say 20 pellets every few days.
>
> Linkadge
Posted by detroitpistons on March 14, 2010, at 13:01:18
In reply to Re: My letter to the FDA » detroitpistons, posted by evenintherain on March 13, 2010, at 15:38:55
OK, so I sent Dr. Laughren my original email, and then I also sent him this (the formatting has been lost):
Hello again Dr. Laughren,
As a follow-up to my original message, Id like to give you some further thoughts and (rhetorical) questions regarding this issue. I was sitting at my computer and I just started typing this, with no particular audience in mind.Its sort of an open letter to anyone who will listen. This is just me thinking out loud (err, in print).
Thanks for reading
A comprehensive, systematic and strategic approach needs to be put into place in order to facilitate the process of discontinuation from antidepressant therapy. Have the pharmaceutical companies conducted any meaningful research on discontinuation? If so, have the data been shared with anyone and/or utilized in the field? I suspect not, and I also suspect that complications from discontinuation are underreported. Im an outsider, so Im just speculating here, but I do have my ear to the ground, so to speak. I would think that research is probably necessary in order to collect the sample data necessary for statistical analysis.Because successful discontinuation is highly individualized and seems to be based on a variety of factors, we need to at least have a sense of the scope of the larger statistical picture. Even based solely on anecdotal accounts and information, is there really any doubt that the frequency of discontinuation complications is indeed statistically significant? So why dont we do something? Dont we need basic distribution ranges of data collected for some of the major variables involved in discontinuation? But do we even know which variables need to be studied? Some things that come to mind are patients dosage sizes, length of treatment prior to discontinuation, titration rates and quantities with corresponding responses and outcomes, largest possible dose size that will still facilitate comfortable discontinuation, etc. Obviously, these are just some things from the top of my head, and Im certainly no expert, but my gut feeling tells me that we dont even really know which variables to measure. Until we decide to measure anything at all, I guess its a moot point.
The current shot in the dark approach and the paucity of information available to practitioners results in haphazard discontinuation planning. The less than optimal discontinuation outcomes that are characterized by significant disruptions of patients daily lives and impairment of their daily functioning are not figments of the imagination. This is a clinical reality and it needs to be treated as such, even if its unprofitable. Research is conducted and data are collected on virtually all other aspects of antidepressant therapy. Why then, is discontinuation not studied, and seemingly, not taken very seriously (as a whole)? If it is studied, then where are the data and are they being utilized? How many million Google hits on (fill in antidepressant) withdrawal do we need to see in order to finally begin to take a scientific approach to this issue?
Its time that pharmaceutical companies are held accountable for what happens after consumers start purchasing their products. Sure, theyll make sure that you have what you need to titrate up, but youre on your own after that. Effectively, they have pawned this responsibility off on ill-prepared physicians and patients. At the very least, drug manufacturers should be made to provide more dose sizes for discontinuation. Again, in this regard, they have placed the onus on practitioners and patients to come up with their own ramshackle solutions. Often this means opening capsules to separate extended release beads into smaller quantities, turning everyday Americans into amateur pharmacists. Often, people end up taking Benadryl or Dramamine or benzodiazepines in order to ease withdrawal (why dont we just call it what it really is?).
Is compounding even possible with extended release formulations? Even in cases which compounding is possible (by real pharmacists, of course!), why should the patients have to bear the responsibility and cost to have this done? Would it really be such a burden to these companies to produce some smaller dosing units and/or oral suspensions/ solutions? I have a hard time believing that the act of manufacturing and distributing these products is a significant barrier. Additionally, depending upon the medication, it can be difficult to get the required combinations of dose sizes, especially when samples are not available, as in the case of Effexor XR. Wyeth has discontinued all samples of Effexor XR (venlafaxine HCl) in favor of the new and improved Pristiq/ desvenlafaxine HCl (gee, what a clever chemical name!). Therefore, doctors and patients have to somehow acquire various dose sizes, essentially on their own. Then of course, in the case of Effexor XR, its not necessarily easy to jump from that last 37.5 mg dose to zero. A huge number of people have reported not being able to make that transition. There seems to be no formal approach to dealing with this issue and in my opinion, physicians are ill equipped to deal with discontinuation challenges. They simply cant prescribe incrementally smaller doses for lack of availability. Something needs to be done.
Its no secret that some of the psychotropic pharmaceutical manufacturers have knowingly failed to inform physicians and patients of the possibility and severity of the so called discontinuation syndrome. The lawsuits and settlements have confirmed this reality. Until we begin to take a methodical approach to the process of discontinuation, all that we have is junk science incredibly irresponsible, unethical, and thoroughly embarrassing, junk science.
Posted by SLS on March 14, 2010, at 14:53:36
In reply to Venlafaxine Suspension, posted by ed_uk2010 on March 12, 2010, at 16:12:52
> Crushed venlafaxine tablets (not m/r caps) can be used as the source of venlafaxine.
I found that the pellets in the Effexor XR preparation worked well to taper with. I simply sprinkled the pellets on my tongue and washed them down with water. No big deal.
- Scott
Posted by detroitpistons on March 14, 2010, at 15:10:27
In reply to Re: Venlafaxine Suspension, posted by SLS on March 14, 2010, at 14:53:36
Were you sitting there counting pellets? That's fine for some people, but it doesn't work for every kind of medication, and not everybody is even going to know that it is an option. Besides, if you have poor eyesight or shaky hands, good luck with that. Some of the people on this board like yourself are probably part of, we'll say, the top 1% of patients with a serious depth of knowledge. Not everybody is like that.
My beef is in principle. We shouldn't have to be doing this crap. It's insane. When a company puts out products like some of these medications, that company has a duty to the consumer. Covering up knowledge of withdrawal and misrepresenting that information, to me, is heinous.
What's so hard about making a kit for tapering?
> > Crushed venlafaxine tablets (not m/r caps) can be used as the source of venlafaxine.
>
> I found that the pellets in the Effexor XR preparation worked well to taper with. I simply sprinkled the pellets on my tongue and washed them down with water. No big deal.
>
>
> - Scott
Posted by evenintherain on March 14, 2010, at 15:43:08
In reply to Re: My letter to the FDA, posted by detroitpistons on March 14, 2010, at 13:01:18
you did a good job of summing up the problems. i hope he responds.
Posted by evenintherain on March 14, 2010, at 15:48:01
In reply to Re: Venlafaxine Suspension, posted by SLS on March 14, 2010, at 14:53:36
i was told by both my pharmacist and my doctor i couldn't do this (with cymbalta, but turns out plenty of people do). i wish they had been able to help me at the time. instead they just said take the lowest dose every other day and then every third day. that was (unsurprisingly) very unhelpful, and just made things worse.
i think drs. need to be more aware of the issue so they can help their patients.
Posted by linkadge on March 14, 2010, at 16:11:55
In reply to Re: Venlafaxine Suspension » SLS, posted by detroitpistons on March 14, 2010, at 15:10:27
Well, there are two possibilities I can think of. One, they don't want you to get off so they don't make smaller doses. Two, they don't make smaller doses because they're only worried about practical sizes for people on the drug.
Linkadge
Posted by linkadge on March 14, 2010, at 16:13:41
In reply to Re: Venlafaxine Suspension » SLS, posted by evenintherain on March 14, 2010, at 15:48:01
off topic, but drug companies are idiots. I am still confused by the recent celebrex comercial. A bunch of old people acting like children then....ask your doctor. Ask my doctor? about what? I have no idea what the drug is for.
Linkadge
Posted by detroitpistons on March 14, 2010, at 16:26:41
In reply to Re: Venlafaxine Suspension, posted by linkadge on March 14, 2010, at 16:13:41
LOL! Exactly. I remember seeing the commercial for Rogaine? I'm pretty sure it was Rogaine. Anyways, I was so confused by that because they didn't say what it was for, at all.
> off topic, but drug companies are idiots. I am still confused by the recent celebrex comercial. A bunch of old people acting like children then....ask your doctor. Ask my doctor? about what? I have no idea what the drug is for.
>
> Linkadge
Posted by detroitpistons on March 14, 2010, at 16:32:51
In reply to Re: Venlafaxine Suspension » SLS, posted by evenintherain on March 14, 2010, at 15:48:01
The easiest drug to come off of for me was Lexapro, but it still wasn't a cakewalk. Lexapro was also more convenient and practical to taper because it's a tablet and you can break it into halves and quarters.
Some people are more sensitive than others, and that's why the medical community should take this more seriously. There are a few people who can just stop, and I envy them. A have a friend who can just quit taking Effexor with no bran zaps, nothing. It's incredible.
> i was told by both my pharmacist and my doctor i couldn't do this (with cymbalta, but turns out plenty of people do). i wish they had been able to help me at the time. instead they just said take the lowest dose every other day and then every third day. that was (unsurprisingly) very unhelpful, and just made things worse.
>
> i think drs. need to be more aware of the issue so they can help their patients.
Posted by detroitpistons on March 14, 2010, at 16:45:16
In reply to Re: Venlafaxine Suspension » SLS, posted by evenintherain on March 14, 2010, at 15:48:01
Did you see slide #8 of the presentation? I love it. It points to the line in the Cymbalta literature that says "You should not break, open, or chew the capsule" and responds with, "Opening the capsules is required to taper!"
> i was told by both my pharmacist and my doctor i couldn't do this (with cymbalta, but turns out plenty of people do). i wish they had been able to help me at the time. instead they just said take the lowest dose every other day and then every third day. that was (unsurprisingly) very unhelpful, and just made things worse.
>
> i think drs. need to be more aware of the issue so they can help their patients.
Posted by ed_uk2010 on March 14, 2010, at 16:48:03
In reply to Re: Venlafaxine Suspension » SLS, posted by evenintherain on March 14, 2010, at 15:48:01
>I was told by both my pharmacist and my doctor i couldn't do this (with cymbalta, but turns out plenty of people do).
Yeah, you can do it. It's the individual pellets which are enteric coated, not the capsule shell. It's important to swallow the pellets whole though ie. no sucking or chewing. The docs and pharmacists are just repeating the manufacturer's information. The manufacturer discourages opening the capsules because some people might suck or chew the pellets and damage the coating. Duloxetine (Cymbalta) is degraded by stomach acid, hence the need for the protective coating.
Posted by ed_uk2010 on March 14, 2010, at 17:01:10
In reply to Re: Venlafaxine Suspension » evenintherain, posted by detroitpistons on March 14, 2010, at 16:45:16
>"You should not break, open, or chew the capsule"
This is typical of the unhelpful information found on product information sheets. Provided that the pellets are placed on the tongue and swallowed straight away, it isn't likely to be a problem. If someone was finding the pellets difficult to swallow quickly enough to ensure that they weren't damaged, it might be helpful to get a pack of empty gelatin capsules and put the pellets in a capsule. Empty capsules can be bought quite cheaply online.
Alternate day dosing is totally inappropriate for short-acting drugs such as Effexor and Cymbalta. It leads to peaks and troughs in blood levels, which only makes matters worse. I find it annoying that some doctors are recommending this harmful practice. Very long-acting drugs such as fluoxetine (Prozac), on the other hand, can often be tapered by reducing the frequency of administration.
Posted by ed_uk2010 on March 14, 2010, at 17:06:42
In reply to Re: Venlafaxine Suspension, posted by SLS on March 14, 2010, at 14:53:36
>I found that the pellets in the Effexor XR preparation worked well to taper with. I simply sprinkled the pellets on my tongue and washed them down with water. No big deal.
Yeah, you're right. It was just a suggestion really. A suspension would be useful for patients who find it difficult to count pellets eg. due to arthritis.
I don't think we'll ever see 'Effexor Taper-Tabs 5mg' on the market, but they would be useful. Has a nice ring to it too.
Posted by Bob on March 14, 2010, at 17:18:21
In reply to Re: Venlafaxine Suspension » evenintherain, posted by detroitpistons on March 14, 2010, at 16:32:51
> The easiest drug to come off of for me was Lexapro, but it still wasn't a cakewalk. Lexapro was also more convenient and practical to taper because it's a tablet and you can break it into halves and quarters.
>
> Some people are more sensitive than others, and that's why the medical community should take this more seriously. There are a few people who can just stop, and I envy them. A have a friend who can just quit taking Effexor with no bran zaps, nothing. It's incredible.That is incredible. We may never know the true reality of what withdrawals are like statistically in severity, duration, and frequency per patient, and the drug companies are extremely motivated to not look into these issues, or not call any attention to what is already know. Doctor's can't be expected to know what it's like if there was never a palpable effort to educate them, much less the victims.
I've often been told when I try to describe my withdrawal problems about how there are other people don't have problems. Because severe withdrawals are a minority percentage they are basically ignored. I'm not sure this will change in our lifetimes.
Go forward in thread:
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
[email protected]
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.